Correlation Between Apogee Therapeutics, and Cementos Pacasmayo

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and Cementos Pacasmayo at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and Cementos Pacasmayo into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apogee Therapeutics, Common and Cementos Pacasmayo SAA, you can compare the effects of market volatilities on Apogee Therapeutics, and Cementos Pacasmayo and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of Cementos Pacasmayo. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and Cementos Pacasmayo.

Diversification Opportunities for Apogee Therapeutics, and Cementos Pacasmayo

0.14
  Correlation Coefficient

Average diversification

The 3 months correlation between Apogee and Cementos is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and Cementos Pacasmayo SAA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cementos Pacasmayo SAA and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with Cementos Pacasmayo. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cementos Pacasmayo SAA has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and Cementos Pacasmayo go up and down completely randomly.

Pair Corralation between Apogee Therapeutics, and Cementos Pacasmayo

Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to generate 2.78 times more return on investment than Cementos Pacasmayo. However, Apogee Therapeutics, is 2.78 times more volatile than Cementos Pacasmayo SAA. It trades about 0.08 of its potential returns per unit of risk. Cementos Pacasmayo SAA is currently generating about 0.03 per unit of risk. If you would invest  1,700  in Apogee Therapeutics, Common on September 3, 2024 and sell it today you would earn a total of  2,815  from holding Apogee Therapeutics, Common or generate 165.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy70.91%
ValuesDaily Returns

Apogee Therapeutics, Common  vs.  Cementos Pacasmayo SAA

 Performance 
       Timeline  
Apogee Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Apogee Therapeutics, is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Cementos Pacasmayo SAA 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cementos Pacasmayo SAA are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound basic indicators, Cementos Pacasmayo is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Apogee Therapeutics, and Cementos Pacasmayo Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Apogee Therapeutics, and Cementos Pacasmayo

The main advantage of trading using opposite Apogee Therapeutics, and Cementos Pacasmayo positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, Cementos Pacasmayo can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cementos Pacasmayo will offset losses from the drop in Cementos Pacasmayo's long position.
The idea behind Apogee Therapeutics, Common and Cementos Pacasmayo SAA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities